ArticleOncotarget2015

Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6.

Yu-Chun Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.